Food and Drug Administration Public Meeting on Financial Efficiency of Human Drug User Fee Programs; Public Meeting; Request for Comments

Краткое содержание

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "FDA Public Meeting on Financial Efficiency of Human Drug User Fee Programs." The topic to be discussed is the financial transparency and efficiency of the Prescription Drug User Fee Act, the Biosimilar User Fee Act, and Generic Drug User Fee Amendments.